| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.048 | 0.8 |